Hebei Ermai Medical Technology Co., Ltd.

Hebei Ermai Medical Technology Co., Ltd. is engaged in business of HA filler, Meso serum, PDO threads, Blunt cannula, Meso needle, and beauty equipment for many years. We are a beauty equipment manufacturer with our own factory, with a group of experienced technicians. We maintain a strict standard in producing our products including appearance design, products assembly, quality test and packing. We provide good service to our customers with excellent design technology, superior quality and good after-sales service.

Hebei Ermai Medical Technology Co., Ltd. Lays emphasis on customers and ensures the quality with quality management system, We have already established OEM business relationships with many domestic and overseas companies. Our goal is to build up a good image for our business partners and make both sides more competitive.

As a leading company in the domestic medical aesthetics field, we specialize in the research, development, production, and sales of high-end medical aesthetic products, including hydrating injectables, hyaluronic acid fillers, and lipolysis. With over 10 years of industry experience, we serve over 100 countries worldwide, partner with over 5, 000 medical and aesthetic institutions, and have served over one million clients. Our exceptional product quality and professional service have earned us numerous prestigious certifications, including CE certification and ISO 13485 medical device quality management system certification.

We consistently prioritize technological innovation as our core competitive advantage, with annual R&D investment exceeding 15% of revenue. We have established a 100-person R&D team in the clinical medicine field and have established strategic partnerships with numerous leading international research institutions. Our core products utilize cutting-edge nano-sustained-release technology and bio-cross-linking processes to ensure safety and long-term effectiveness. Our hydrating products and hyaluronic acid series are CE-certified by the European Union, and our lipolysis technology has demonstrated significant clinical results.